Toggle navigation
Languages
English
繁體中文
About
Technologies
Solutions
Services
Downloads
Contact
Careers
Location
Investor
Languages
English
繁體中文
Assay Techniques and Test Development for COVID-19 Diagnosis
Home
Latest News
Latest News
Assay Techniques and Test Development for COVID-19 Diagnosis
An ongoing theme of the COVID-19 pandemic is the need for widespread availability of accurate and efficient diagnostic testing for the detection of SARS-CoV-2 and antiviral antibodies in infected individuals. This report describes various assay techniques and tests for COVID-19 diagnosis. Most tests for early detection of SARS-CoV-2 RNA rely on the reverse transcription-polymerase chain reaction, but isothermal nucleic acid amplification assays, including transcription-mediated amplification and CRISPR-based methodologies, are promising alternatives. Identification of individuals who have developed antibodies to the SARS-CoV-2 virus requires serological tests, including enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay. This report also provides an overview of current development in COVID-19 diagnostic techniques and products to facilitate future improvement and innovation.
Back to the top
Design by WebTech
Webpage design